Evaluation of Isooxazoline derivatives in the Treatment of Canine Demodicosis
Keywords:
afoxolaner, Demodex canis, fluralaner, sarolanerAbstract
Canine demodicosis is a common dermatological condition observed indogs. The aim of this study was to evaluate the effectiveness of isooxazoline derivatives for the treatment of demodicosis compared to ivermectin.Forty-one dogs with demodicosis were treated with ivermectin (n=13), fluralaner(n=5), sarolaner(n=11) and afoxolaner (n=12),respectively. The mite count was evaluated on day 0, 28, 56 and 84 of treatment period. A single oral dose of isooxazoline derivatives reduced Demodex mite counts in skin scrapings by an average of 98.6% in all dogs by 28th day and 100% by 84th day. Single administration of ivermectin resulted to be only 76.8% effective. No adverse effects of drugs were observed in any of the dogs.
Downloads
References
Beugnet, F., Halos, L., Larsen, D., and de Vos, C. (2016)Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis. Parasite.23:14.
Chander, R., Choudhary, S., Singh, AP., Kachhawa, J. P., and Saharan, D.K. (2020) Comparative evaluation of different therapy for canine demodicosis. J. Entomol. Zool. Stud.8(3): 1534-1539.
Deepak, D., Chaudhary, A. K., Yadav, S., Das, A. K., Patel, P.K., Paul, B. R., De, U. K. and Dixit, S. K.,(2018) Clinical investigation and therapeutic management of canine demodicosis with doramectin: A case study. J. Entomol. Zool. Stud.6(6): 1012-1015.
Fourie, J. J., Liebenberg, J. E., Horak, I. G., Taenzler, J., Heckeroth, A. R., and Frenais, R. (2015) Efficacy of orally administered Fluralaner (BravectoTM) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs. Parasit.Vectors.8(1): 1-7.
Gupta, N., and Prasad, B. (2001) Clinical diagnosis and therapeutic management of Acariasis in dogs. Indian Vet. J.21(2): 73-75.
Kumar, P., and Shekhar,S. (2020) Occurrence of dermatological disorders and Haemato biochemical alteration, treatment of Demodicosis in dogs. J. Entomol. Zool.8: 126-132.
Lebon, W., Beccati, M., Bourdeau, P., Brement, T., Bruet, V., Cekiera, A., Crosaz, O., Darmon, C., Guillot, J., Mosca, M. and Pin, D. (2018) Efficacy of two formulations of Afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in EuropeParasit. Vectors.11(1): 1-10.
Nam, H., Yun, T., Koo, Y., Chae, Y., Lee, D., Park, J., Choi, Y., Kim, H., Yang, M. P. and Kang, B. T. (2021) Oral Fluralaner Treatment in a Dog with Desperate Demodicosis: A Case Report. J. Vet. Clin.38(4): 169-173.
Noli, C. (2000) Practical laboratory methods for the diagnosis of dermatologic diseases. In: Bonagura JB (Editor), Current Veterinary Therapy-Small Animal Practice XIII. WB Saunders, Philadelphia, 13: 526-530.
Petersen, I., Chiummo, R., Zschiesche, E., Karas-Tecza, J., Rapti, D., Roepke, R. and Thomas, E. (2020) A European Field Assessment of the efficacy of fluralaner (Bravecto®) chewable and spot-on formulations for treatment of client-owned dogs with generalized demodicosis.Parasit. Vectors.13, 304.
Plumb, D.C.(2005) Veterinary Drug Handbook. 5th edition, Pharma Vet Inc., Wisconsin, pp.: 18-20.
Ramsey, I. K.(Ed.) (2017) BSAVA Small Animal Formulary: Part A, Canine and Feline. 9th edition, British Small Animal Veterinary Association, Gloucester.
Salem, N.Y., Abdel-Saeed, H., Farag, H. S., and Ghandour, R. A. (2020) Canine demodicosis: Hematological and biochemical alterations. Vet. World13(1): 68.
Six, R. H., Becskei, C., Mazaleski, M. M., Fourie, J. J., Mahabir, S. P., Myers, M. R., and Slootmans, N. (2016) Efficacy of Sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectescynotis. Vet. Parasitol.222: 62-66.
Thapa,G., and Sarkar, S. (2018) Occurrence of Canine Skin Disorder and its Hematobiochemical Alterations. Int. J.Curr.Microbiol.Appl. Sci.7(12): 184-195.